March 13, 2026

Hydrus®: Designed with Purpose

Professor Norbert Pfeiffer explores the features and benefits of the Hydrus® Microstent

The Ophthalmologist

March 12, 2026

Beyond IOP: The Mood Effects of CAIs

Evidence from large US dataset suggests topical carbonic Anhydrase Inhibitors may increase depression risk in glaucoma patients

The Ophthalmologist

March 05, 2026

Medical Oddities: The Calmest Move in Cardiology?

Yoga for SVT, romantic brain bias, dog-made air chemistry, math learning clues, selenium tea, and glaucoma pillows—medicine’s weekly roundup of strange.

Conexiant

March 05, 2026

Targeting Trabecular Meshwork Metabolism

Study suggests potential new vitamin B3 treatment for glaucoma protection

The Ophthalmologist

March 04, 2026

SEE Program Strengthens Adherence

Personalized glaucoma coaching program boosts medication adherence and reduces stress in randomized trial

Conexiant

March 04, 2026

The Blood–Glaucoma Connection

Could red blood cells help predict glaucoma?

The Ophthalmologist

October 01, 2025

Of Imaging and Algorithms

Explore how AI is transforming ophthalmology through advanced imaging technologies that enhance diagnosis and patient outcomes.

Ophthalmology Management

February 12, 2026

Fellow Eyes Reveal Angle Closure Clues

The “quiet” fellow eye in primary angle-closure glaucoma may not be so quiet…

The Ophthalmologist

January 01, 2018

Glaucoma Novel IOP-lowering drugs

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Ophthalmic Professional

January 01, 2020

CONTACT LENS CASE REPORTS

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Contact Lens Spectrum